![](http://www.uhnresearch.ca/sites/default/files/styles/profile_photo/public/profile_images/pi_49705_0.jpg?itok=ZCgHyS8b)
Jeremy Sivak, PhD holds the Glaucoma Research Chair at the Krembil Research Institute, University Health Network, and is a Professor of Ophthalmology & Vision Sciences at the University of Toronto. Dr. Sivak completed his PhD in 2001 at Tufts University/New England Medical Center, followed by a postdoctoral fellowship at the University of Cambridge. He then joined Novartis in 2005 as a project lead where he led multidisciplinary ophthalmic drug discovery teams. Dr. Sivak returned to academics in 2010 to establish a research program that examines the mechanisms controlling retinal injury responses, and to design new treatment and drug delivery strategies. The success of this work is reflected in concurrent funding from federal, and non-profit granting agencies, industry collaborations, consistent publications in prominent journals, and broad lecturing internationally.